Rheumatoid factor isotype and Ro epitope distribution in primary Sjögren syndrome and rheumatoid arthritis with keratoconjunctivitis sicca
- PMID: 29936570
- DOI: 10.1007/s00296-018-4090-5
Rheumatoid factor isotype and Ro epitope distribution in primary Sjögren syndrome and rheumatoid arthritis with keratoconjunctivitis sicca
Abstract
Primary Sjögren syndrome (pS) is associated with autoantibodies such as rheumatoid factor (RF) and anti-nuclear antibodies such as anti-Ro (SS-A) and/or La (SS-B). Recent developments within autoimmune diagnostics allow quantitation of RF subclasses and anti-Ro epitopes. Will this refinement by autoimmune diagnostics help predicting development of extraglandular manifestations (EGM) in pS patients? A cohort of pS and rheumatoid arthritis (RA) patients with keratoconjunctivitis sicca (n = 35 and 16, resp) was included. Of the pS patients, 54% developed one or more EGM. Antibodies quantitated were IgM-RF, IgA-RF, IgG-RF, anti-Ro52, and anti-Ro60. Upon analysis of RF isotypes, pS patients generally displayed higher IgA-RF concentrations than RA patients (126 versus 49 U/ml, p = 0.015), while the dominant RF isotype in RA patients was IgM-RF (82.5 versus 38 U/ml, p = 0.012). No differences were observed regarding IgG-RF concentrations. In pS without/with EGM, the median RF IgM concentrations were similar, while RF IgA and IgG concentrations tended to be lower in pS patients with EGM > 1. Both Ro epitopes were strongly recognized by almost all pS patients, independent from EGM, while these antibodies were absent in RA patients. Primary Sjögren syndrome and RA patients have distinct serological profiles when analysing RF and Ro-specific antibodies. A longitudinal study of switched RF isotypes in pS patients is worthwhile from an immunological point of view, but its value is limited regarding identification of pS patients prone to developing EGM or RA patients prone to developing secondary sicca symptoms.
Keywords: Extraglandular manifestations; Isotype; Rheumatoid arthritis; Rheumatoid factor; Ro; Sjögren.
Similar articles
-
Additive Value of Rheumatoid Factor Isotypes in Sjögren's Syndrome Patients with Joint Complaints of Different Etiologies-Can Rheumatoid Factor IgA Serve as an Early, Poor Prognostic Biomarker Candidate?Int J Mol Sci. 2025 May 16;26(10):4797. doi: 10.3390/ijms26104797. Int J Mol Sci. 2025. PMID: 40429937 Free PMC article.
-
Anti-agalactosyl IgG antibodies and isotype profiles of rheumatoid factors in Sjögren's syndrome and rheumatoid arthritis.Clin Exp Rheumatol. 1998 Nov-Dec;16(6):709-15. Clin Exp Rheumatol. 1998. PMID: 9844764
-
IgA immunoglobulin isotype of rheumatoid factor in primary Sjögren's syndrome.Rheumatol Int. 2021 Mar;41(3):643-649. doi: 10.1007/s00296-020-04782-3. Epub 2021 Jan 26. Rheumatol Int. 2021. PMID: 33496802 Free PMC article.
-
The Potential Role for Early Biomarker Testing as Part of a Modern, Multidisciplinary Approach to Sjögren's Syndrome Diagnosis.Adv Ther. 2017 Apr;34(4):799-812. doi: 10.1007/s12325-017-0501-3. Epub 2017 Mar 10. Adv Ther. 2017. PMID: 28283891 Review.
-
[Epidemiology of primary Sjörgren's syndrome].Z Rheumatol. 2010 Feb;69(1):41-9. doi: 10.1007/s00393-009-0518-3. Z Rheumatol. 2010. PMID: 20012976 Review. German.
Cited by
-
Sicca syndrome in the same family - the importance of anti-Ro60, anti-Ro52 and anti-La antibody profiling in Sjögren's syndrome.Reumatologia. 2021;59(4):260-264. doi: 10.5114/reum.2021.108653. Epub 2021 Aug 20. Reumatologia. 2021. PMID: 34538957 Free PMC article.
-
Rheumatoid Factor: A Novel Determiner in Cancer History.Cancers (Basel). 2021 Feb 3;13(4):591. doi: 10.3390/cancers13040591. Cancers (Basel). 2021. PMID: 33546243 Free PMC article.
-
Different rheumatoid factor binding patterns distinguish between Sjögren's disease with or without associated RA.RMD Open. 2025 Jun 22;11(2):e005386. doi: 10.1136/rmdopen-2024-005386. RMD Open. 2025. PMID: 40545271 Free PMC article.
-
Roles of TRIM21/Ro52 in connective tissue disease-associated interstitial lung diseases.Front Immunol. 2024 Aug 6;15:1435525. doi: 10.3389/fimmu.2024.1435525. eCollection 2024. Front Immunol. 2024. PMID: 39165359 Free PMC article. Review.
-
Ocular Manifestations Related to Antibodies Positivity and Inflammatory Biomarkers in a Rheumatological Cohort.Clin Ophthalmol. 2022 Aug 9;16:2477-2490. doi: 10.2147/OPTH.S361243. eCollection 2022. Clin Ophthalmol. 2022. PMID: 35971506 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous